mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.4 |
mRNA |
BRD-K96431673 |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.4 |
mRNA |
Dasatinib |
FIMM |
pan-cancer |
AAC |
-0.16 |
0.4 |
mRNA |
BRD-K03911514 |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.4 |
mRNA |
SB590885 |
GDSC1000 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
Bleomycin |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.4 |
mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
0.037 |
0.4 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
GDC-0941 |
gCSI |
pan-cancer |
AAC |
0.054 |
0.4 |